Synergistic inhibition of mesothelioma cell growth by the combination of clofarabine and resveratrol involves nrf2 downregulation

BMB Reports

Volumn 45, Issue 11, 2012, Pages 647-652

  Lee, Yoon Jin ^a   Im, Jae Hyuk ^a   Lee, David M ^b   Par, Ji Sung ^a   Won, Seong Youn ^a   Cho, Moon Kyun ^a   Nam, Hae Seon ^a   Lee, Yong Jin ^a   Lee, Sang Han ^a  

^a Soonchunhyang University   (South Korea)

^b University of Maryland   (United States)

Author keywords

Chemoresistance; Clofarabine; Mesothelioma; Nrf2; Resveratrol

Indexed keywords

ADENINE NUCLEOTIDE; ANTINEOPLASTIC AGENT; ARABINONUCLEOSIDE; CLOFARABINE; HEME OXYGENASE 1; NFE2L2 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RESVERATROL; SMALL INTERFERING RNA; STILBENE DERIVATIVE; TRANSCRIPTION FACTOR NRF2;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HUMAN; MESOTHELIOMA; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ADENINE NUCLEOTIDES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; ARABINONUCLEOSIDES; BLOTTING, WESTERN; CELL PROLIFERATION; DOWN-REGULATION; DRUG SYNERGISM; HEME OXYGENASE-1; HUMANS; MESOTHELIOMA; NF-E2-RELATED FACTOR 2; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STILBENES; TUMOR CELLS, CULTURED;

EID: 84871453477     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2012.45.11.111     Document Type: Article

References (21)

1. Belli, C., Fennell, D., Giovannini, M., Gaudino, G. and Mutti, L. (2009) Malignant pleural mesothelioma: current treatments and emerging drugs. Expert. Opin. Emerg. Drugs 14, 423-437.
2. Kim, K. U., Wilson, S. M., Abayasiriwardana, K. S., Collins, R., Fjellbirkeland, L., Xu, Z., Jablons, D. M., Nishimura, S. L. and Broaddus, V. C. (2005) A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance. Am. J. Respir. Cell Mol. Biol. 33, 541-548.
3. Kensler, T. W., Wakabayashi, N. and Biswal, S. (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47, 89-116.
4. Zhang, D. D. and Hannink, M. (2003) Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23, 8137-8151.
5. Jiang, T., Chen, N., Zhao, F., Wang, X. J., Kong, B., Zheng, W. and Zhang, D. D. (2010) High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res. 70, 5486-5496.
6. Zhang, P., Singh, A., Yegnasubramanian, S., Esopi, D., Kombairaju, P., Bodas, M., Wu, H., Bova, S. G. and Biswal, S. (2010) Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol. Cancer Ther. 9, 336-346.
7. Kim, S. K., Yang, J. W., Kim, M. R., Roh, S. H., Kim, H. G., Lee, K. Y., Jeong, H. G. and Kang, K. W. (2008) Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells. Free Radic. Biol. Med. 45, 537-546.
8. Lee, Y. J., Jeong, H. Y., Kim, Y. B., Lee, Y. J., Won, S. Y., Shim, J. H., Cho, M. K., Nam, H. S. and Lee, S. H. (2012) Reactive oxygen species and PI3K/Akt signaling play key roles in the induction of Nrf2-driven heme oxygenase-1 expression in sulforaphane-treated human mesothelioma MSTO-211H cells. Food Chem. Toxicol. 50, 116-123.
9. Shakibaei, M., Harikumar, K. B. and Aggarwal, B. B. (2009) Resveratrol addiction: to die or not to die. Mol. Nutr. Food Res. 53, 115-128.
10. Homma, S., Ishii, Y., Morishima, Y., Yamadori, T., Matsuno, Y., Haraguchi, N., Kikuchi, N., Satoh, H., Sakamoto, T., Hizawa, N., Itoh, K. and Yamamoto, M. (2009) Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin. Cancer Res. 15, 3423-3432.
11. Shibata, T., Kokubu, A., Saito, S., Narisawa-Saito, M., Sasaki, H., Aoyagi, K., Yoshimatsu, Y., Tachimori, Y., Kushima, R., Kiyono, T. and Yamamoto, M. (2011) NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer. Neoplasia 13, 864-873.
12. Santandreu, F. M., Valle, A., Oliver, J. and Roca, P. (2011) Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells. Cell Physiol. Biochem. 28, 219-228.
13. Quan, F., Pan, C., Ma, Q., Zhang, S. and Yan, L. (2008) Reversal effect of resveratrol on multidrug resistance in KBv200 cell line. Biomed. Pharmacother. 62, 622-629.
14. Berberat, P. O., Dambrauskas, Z., Gulbinas, A., Giese, T., Giese, N., Künzli, B., Autschbach, F., Meuer, S., Büchler, M. W. and Friess, H. (2005) Inhibition of heme oxygenase- 1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin. Cancer Res. 11, 3790-3798.
15. Frampton, G. A., Lazcano, E. A., Li, H., Mohamad, A. and DeMorrow, S. (2010) Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents. Lab. Invest. 90, 1325-1338.
16. Suzuki, Y., Murakami, H., Kawaguchi, K., Taniguchi, T., Fujii, M., Shinjo, K., Kondo, Y., Osada, H., Shimokata, K., Horio, Y., Hasegawa, Y., Hida, T. and Sekido, Y. (2009) Activation of the PI3KAKT pathway in human malignant mesothelioma cells. Mol. Med. Rep. 2, 181-188.
17. Tajima, K., Ohashi, R., Sekido, Y., Hida, T., Nara, T., Hashimoto, M., Iwakami, S., Minakata, K., Yae, T., Takahashi, F., Saya, H. and Takahashi, K. (2010) Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells. Oncogene 29, 1941-1951.
18. Martin, D., Rojo, A. I., Salinas, M., Diaz, R., Gallardo, G., Alam, J., De Galarreta, C. M. and Cuadrado, A. (2004) Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3 kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical, carnosol. J. Biol. Chem. 279, 8919-8929.
19. Reisman, S. A., Aleksunes, L. M. and Klaassen, C. D. (2009) Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes. Biochem. Pharmacol. 77, 1273-1282.
20. Ramanathan, B., Jan, K. Y., Chen, C. H., Hour, T. C., Yu, H. J. and Pu, Y. S. (2005) Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res. 65, 8455-8460.
21. Kinnula, V. L., Pääkkö, P. and Soini, Y. (2004) Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett. 569, 1-6.